.png)
Radioactive Stents Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 152 Category: Pharma & Healthcare Report Code : HC0912760
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Radioactive Stents MarketBy Type (Retrograde Stents, Antegrade Stents, Internal (double-j) Stents, Iodine-125 Radioactive Stents, and Others), Application (Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy, Angiography, Neointimal Hyperplasia, Esophageal Cancer, Biliary Cancer, and Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Radioactive Stents Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Radioactive Stents are used in prevention of restenosis and coronary artery lesions, and in improving catheter-based revascularization.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Radioactive Stents Marketsize market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- C.R. Bard, Inc.
- Cook Medical Inc.
- Medline Industries Ltd
- Pnn Medical A/S
- Allium Medical Solutions Ltd.
- APC Cardiovascular Ltd.
- Micro-Tech Pvt. Ltd.
- Changzhou Zhiye Co Ltd.
- Aetna Inc.
- Abbott Laboratories.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Radioactive Stents Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Retrograde Stents
o Antegrade Stents
o Internal (double-j) Stents
o Iodine-125 Radioactive Stents
o Others
· Radioactive Stents Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Lithotripsy
o Ureteroscopy
o Ureteroenoscopy
o Percutaneous Nephrolithotomy
o Angiography
o Neointimal Hyperplasia
o Esophageal Cancer
o Biliary Cancer
o Others
· Radioactive Stents Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o C.R. Bard, Inc.
o Cook Medical Inc.
o Medline Industries Ltd
o Pnn Medical A/S
o Allium Medical Solutions Ltd.
o APC Cardiovascular Ltd.
o Micro-Tech Pvt. Ltd.
o Changzhou Zhiye Co Ltd.
o Aetna Inc.
o Abbott Laboratories
· Radioactive Stents Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Radioactive Stents Market , By Country
o U.S. Radioactive Stents Market
o Canada Radioactive Stents Market
o Mexico Radioactive Stents Market
o Europe
§ Europe Radioactive Stents Market , By Country
o UK Radioactive Stents Market
o Germany Radioactive Stents Market
o France Radioactive Stents Market
o Russia Radioactive Stents Market
o Italy Radioactive Stents Market
o Rest of Europe Radioactive Stents Market
o Asia-Pacific
§ Asia-Pacific Radioactive Stents Market , By Country
o China Radioactive Stents Market
o Japan Radioactive Stents Market
o South Korea Radioactive Stents Market
o India Radioactive Stents Market
o Southeast Asia Radioactive Stents Market
o Rest of Asia-Pacific Radioactive Stents Market
o South America
§ South America Radioactive Stents Market
o Brazil Radioactive Stents Market
o Argentina Radioactive Stents Market
o Columbia Radioactive Stents Market
o Rest of South America Radioactive Stents Market
o Middle East and Africa
§ Middle East and Africa Radioactive Stents Market
o Saudi Arabia Radioactive Stents Market
o UAE Radioactive Stents Market
o Egypt Radioactive Stents Market
o Nigeria Radioactive Stents Market
o South Africa Radioactive Stents Market
o Rest of MEA Radioactive Stents Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Radioactive Stents Market, By Product Type
5.1. Introduction
5.2. Global Radioactive Stents Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Radioactive Stents Revenue and Revenue Share by Product Type (2017-2021)
5.3. Retrograde Stents
5.3.1. Global Retrograde Stents Revenue and Growth Rate (2017-2021)
5.4. Antegrade Stents
5.4.1. Global Antegrade Stents Revenue and Growth Rate (2017-2021)
5.5. Internal (double-j) Stents
5.5.1. Global Internal (double-j) Stents Revenue and Growth Rate (2017-2021)
5.6. Iodine-125 Radioactive Stents
5.6.1. Global Iodine-125 Radioactive Stents Revenue and Growth Rate (2017-2021)
5.7. Others
5.7.1. Global Others Revenue and Growth Rate (2017-2021)
6. Radioactive Stents Market, By Applications
6.1. Introduction
6.2. Global Radioactive Stents Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Radioactive Stents Revenue and Revenue Share by Applications (2017-2021)
6.3. Lithotripsy
6.3.1. Global Lithotripsy Revenue and Growth Rate (2017-2021)
6.4. Ureteroscopy
6.4.1. Global Ureteroscopy Revenue and Growth Rate (2017-2021)
6.5. Ureteroenoscopy
6.5.1. Global Ureteroenoscopy Revenue and Growth Rate (2017-2021)
6.6. Percutaneous Nephrolithotomy
6.6.1. Global Percutaneous Nephrolithotomy Revenue and Growth Rate (2017-2021)
6.7. Angiography
6.7.1. Global Angiography Revenue and Growth Rate (2017-2021)
6.8. Neointimal Hyperplasia
6.8.1. Global Neointimal Hyperplasia Revenue and Growth Rate (2017-2021)
6.9. Esophageal Cancer
6.9.1. Global Esophageal Cancer Revenue and Growth Rate (2017-2021)
6.10. Biliary Cancer
6.10.1. Global Biliary Cancer Revenue and Growth Rate (2017-2021)
6.11. Others
6.11.1. Global Others Revenue and Growth Rate (2017-2021)
7. Radioactive Stents Market, By Region
7.1. Introduction
7.2. Global Radioactive Stents Revenue and Market Share by Regions
7.2.1. Global Radioactive Stents Revenue by Regions (2017-2021)
7.3. North America Radioactive Stents by Countries
7.3.1. North America Radioactive Stents Revenue and Growth Rate (2017-2021)
7.3.2. North America Radioactive Stents Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Radioactive Stents by Countries
7.4.1. Europe Radioactive Stents Revenue and Growth Rate (2017-2021)
7.4.2. Europe Radioactive Stents Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Radioactive Stents by Countries
7.5.1. Asia-Pacific Radioactive Stents Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Radioactive Stents Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Radioactive Stents by Countries
7.6.1. South America Radioactive Stents Revenue and Growth Rate (2017-2021)
7.6.2. South America Radioactive Stents Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Radioactive Stents by Countries
7.7.1. Middle East and Africa Radioactive Stents Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Radioactive Stents Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. C.R. Bard, Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Cook Medical Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Medline Industries Ltd
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Pnn Medical A/S
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Allium Medical Solutions Ltd.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. APC Cardiovascular Ltd.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Micro-Tech Pvt. Ltd.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Changzhou Zhiye Co Ltd.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Aetna Inc.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Abbott Laboratories
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Radioactive Stents Market Forecast (2022-2027)
9.1. Global Radioactive Stents Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Radioactive Stents Market Forecast by Regions (2022-2027)
9.2.1. North America Radioactive Stents Market Forecast (2022-2027)
9.2.1.1. United States Radioactive Stents Market Forecast (2022-2027)
9.2.1.2. Canada Radioactive Stents Market Forecast (2022-2027)
9.2.1.3. Mexico Radioactive Stents Market Forecast (2022-2027)
9.2.2. Europe Radioactive Stents Market Forecast (2022-2027)
9.2.2.1. Germany Radioactive Stents Market Forecast (2022-2027)
9.2.2.2. France Radioactive Stents Market Forecast (2022-2027)
9.2.2.3. UK Radioactive Stents Market Forecast (2022-2027)
9.2.2.4. Russia Radioactive Stents Market Forecast (2022-2027)
9.2.2.5. Italy Radioactive Stents Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Radioactive Stents Market Forecast (2022-2027)
9.2.3. Asia-Pacific Radioactive Stents Market Forecast (2022-2027)
9.2.3.1. China Radioactive Stents Market Forecast (2022-2027)
9.2.3.2. Japan Radioactive Stents Market Forecast (2022-2027)
9.2.3.3. Korea Radioactive Stents Market Forecast (2022-2027)
9.2.3.4. India Radioactive Stents Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Radioactive Stents Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Radioactive Stents Market Forecast (2022-2027)
9.2.4. South America Radioactive Stents Market Forecast (2022-2027)
9.2.4.1. Brazil Radioactive Stents Market Forecast (2022-2027)
9.2.4.2. Argentina Radioactive Stents Market Forecast (2022-2027)
9.2.4.3. Columbia Radioactive Stents Market Forecast (2022-2027)
9.2.4.4. Rest of South America Radioactive Stents Market Forecast (2022-2027)
9.2.5. Middle East and Africa Radioactive Stents Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Radioactive Stents Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Radioactive Stents Market Forecast (2022-2027)
9.2.5.3. Egypt Radioactive Stents Market Forecast (2022-2027)
9.2.5.4. Nigeria Radioactive Stents Market Forecast (2022-2027)
9.2.5.5. South Africa Radioactive Stents Market Forecast (2022-2027)
9.2.5.6. Turkey Radioactive Stents Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Radioactive Stents Market Forecast (2022-2027)
9.3. Radioactive Stents Market Forecast by Product Type (2022-2027)
9.3.1. Radioactive Stents Forecast by Product Type (2022-2027)
9.3.2. Radioactive Stents Market Share Forecast by Product Type (2022-2027)
9.4. Radioactive Stents Market Forecast by Applications (2022-2027)
9.4.1. Radioactive Stents Forecast by Applications (2022-2027)
9.4.2. Radioactive Stents Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Radioactive Stents Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Radioactive Stents Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Retrograde Stents Revenue and Growth Rate (2017-2019)
Figure Global Antegrade Stents Revenue and Growth Rate (2017-2019)
Figure Global Internal (double-j) Stents Revenue and Growth Rate (2017-2019)
Figure Global Iodine-125 Radioactive Stents Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Radioactive Stents Revenue and Revenue Share by Applications (2017-2019)
Figure Global Lithotripsy Revenue and Growth Rate (2017-2019)
Figure Global Ureteroscopy Revenue and Growth Rate (2017-2019)
Figure Global Ureteroenoscopy Revenue and Growth Rate (2017-2019)
Figure Global Percutaneous Nephrolithotomy Revenue and Growth Rate (2017-2019)
Figure Global Angiography Revenue and Growth Rate (2017-2019)
Figure Global Neointimal Hyperplasia Revenue and Growth Rate (2017-2019)
Figure Global Esophageal Cancer Revenue and Growth Rate (2017-2019)
Figure Global Biliary Cancer Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Radioactive Stents Revenue by Regions (2017-2019)
Figure North America Radioactive Stents Growth Rate (2017-2019)
Figure North America Radioactive Stents Revenue and Growth Rate (2017-2019)
Figure North America Radioactive Stents by Countries (2017-2019)
Figure North America Radioactive Stents Revenue (Million USD) by Countries (2017-2019)
Figure United States Radioactive Stents Growth Rate (2017-2019)
Figure United States Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Radioactive Stents Growth Rate (2017-2019)
Figure Canada Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Radioactive Stents Growth Rate (2017-2019)
Figure Mexico Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Radioactive Stents Growth Rate (2017-2019)
Figure Europe Radioactive Stents Revenue and Growth Rate (2017-2019)
Figure Europe Radioactive Stents by Countries (2017-2019)
Figure Europe Radioactive Stents Revenue (Million USD) by Countries (2017-2019)
Figure Germany Radioactive Stents Growth Rate (2017-2019)
Figure Germany Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Radioactive Stents Growth Rate (2017-2019)
Figure France Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Radioactive Stents Growth Rate (2017-2019)
Figure UK Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Radioactive Stents Growth Rate (2017-2019)
Figure Russia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Radioactive Stents Growth Rate (2017-2019)
Figure Italy Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Radioactive Stents Growth Rate (2017-2019)
Figure Rest of Europe Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Radioactive Stents Growth Rate (2017-2019)
Figure Asia-Pacific Radioactive Stents Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Radioactive Stents by Countries (2017-2019)
Figure Asia-Pacific Radioactive Stents Revenue (Million USD) by Countries (2017-2019)
Figure China Radioactive Stents Growth Rate (2017-2019)
Figure China Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Radioactive Stents Growth Rate (2017-2019)
Figure Japan Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Radioactive Stents Growth Rate (2017-2019)
Figure Korea Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Radioactive Stents Growth Rate (2017-2019)
Figure India Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Radioactive Stents Growth Rate (2017-2019)
Figure Southeast Asia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Radioactive Stents Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Radioactive Stents Growth Rate (2017-2019)
Figure South America Radioactive Stents Revenue and Growth Rate (2017-2019)
Figure South America Radioactive Stents by Countries (2017-2019)
Figure South America Radioactive Stents Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Radioactive Stents Growth Rate (2017-2019)
Figure Brazil Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Radioactive Stents Growth Rate (2017-2019)
Figure Argentina Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Radioactive Stents Growth Rate (2017-2019)
Figure Columbia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Radioactive Stents Growth Rate (2017-2019)
Figure Rest of South America Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Radioactive Stents Growth Rate (2017-2019)
Figure Middle East and Africa Radioactive Stents Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Radioactive Stents by Countries (2017-2019)
Figure Middle East and Africa Radioactive Stents Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Radioactive Stents Growth Rate (2017-2019)
Figure Saudi Arabia Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Radioactive Stents Growth Rate (2017-2019)
Figure United Arab Emirates Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Radioactive Stents Growth Rate (2017-2019)
Figure Egypt Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Radioactive Stents Growth Rate (2017-2019)
Figure Nigeria Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Radioactive Stents Growth Rate (2017-2019)
Figure South Africa Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Radioactive Stents Growth Rate (2017-2019)
Figure Turkey Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Radioactive Stents Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Radioactive Stents Revenue (Millions USD) and Growth Rate (2017-2019)
Table C.R. Bard, Inc. Radioactive Stents Financial Overview
Table Cook Medical Inc. Radioactive Stents Financial Overview
Table Medline Industries Ltd Radioactive Stents Financial Overview
Table Pnn Medical A/S Radioactive Stents Financial Overview
Table Allium Medical Solutions Ltd. Radioactive Stents Financial Overview
Table APC Cardiovascular Ltd. Radioactive Stents Financial Overview
Table Micro-Tech Pvt. Ltd. Radioactive Stents Financial Overview
Table Changzhou Zhiye Co Ltd. Radioactive Stents Financial Overview
Table Aetna Inc. Radioactive Stents Financial Overview
Table Abbott Laboratories Radioactive Stents Financial Overview
Figure Global Radioactive Stents Revenue (Millions USD) and Growth Rate (2019-2027)
Table Radioactive Stents Market Forecast by Regions (2019-2027)
Figure North America Radioactive Stents Market Forecast (2019-2027)
Figure United States Radioactive Stents Market Forecast (2019-2027)
Figure Canada Radioactive Stents Market Forecast (2019-2027)
Figure Mexico Radioactive Stents Market Forecast (2019-2027)
Figure Europe Radioactive Stents Market Forecast (2019-2027)
Figure Germany Radioactive Stents Market Forecast (2019-2027)
Figure France Radioactive Stents Market Forecast (2019-2027)
Figure UK Radioactive Stents Market Forecast (2019-2027)
Figure Russia Radioactive Stents Market Forecast (2019-2027)
Figure Italy Radioactive Stents Market Forecast (2019-2027)
Figure Rest of Europe Radioactive Stents Market Forecast (2019-2027)
Figure Asia-Pacific Radioactive Stents Market Forecast (2019-2027)
Figure China Radioactive Stents Market Forecast (2019-2027)
Figure Japan Radioactive Stents Market Forecast (2019-2027)
Figure Korea Radioactive Stents Market Forecast (2019-2027)
Figure India Radioactive Stents Market Forecast (2019-2027)
Figure Southeast Asia Radioactive Stents Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Radioactive Stents Market Forecast (2019-2027)
Figure South America Radioactive Stents Market Forecast (2019-2027)
Figure Brazil Radioactive Stents Market Forecast (2019-2027)
Figure Argentina Radioactive Stents Market Forecast (2019-2027)
Figure Columbia Radioactive Stents Market Forecast (2019-2027)
Figure Rest of South America Radioactive Stents Market Forecast (2019-2027)
Figure Middle East and Africa Radioactive Stents Market Forecast (2019-2027)
Figure Saudi Arabia Radioactive Stents Market Forecast (2019-2027)
Figure United Arab Emirates Radioactive Stents Market Forecast (2019-2027)
Figure Egypt Radioactive Stents Market Forecast (2019-2027)
Figure Nigeria Radioactive Stents Market Forecast (2019-2027)
Figure South Africa Radioactive Stents Market Forecast (2019-2027)
Figure Turkey Radioactive Stents Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Radioactive Stents Market Forecast (2019-2027)
Figure Global Radioactive Stents Forecast by Product Type (2019-2027)
Figure Global Radioactive Stents Market Share Forecast by Product Type (2019-2027)
Figure Global Radioactive Stents Forecast by Product Type (2019-2027)
Figure Global Radioactive Stents Forecast by Applications (2019-2027)
Figure Global Radioactive Stents Market Share Forecast by Applications (2019-2027)
Figure Global Radioactive Stents Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|